GERMAmplify Treatments, Testing...


$ 19.10 $ -0.06 (-0.29 %)    

Thursday, 29-Aug-2024 13:50:48 EDT
QQQ $ 473.89 $ -2.08 (-0.44 %)
DIA $ 417.12 $ -0.26 (-0.06 %)
SPY $ 563.14 $ 0.30 (0.05 %)
TLT $ 100.82 $ -0.51 (-0.5 %)
GLD $ 237.35 $ -1.31 (-0.55 %)
$ 19.1577
-- x --
-- x --
-- - --
$ 16.24 - $ 20.10
4,828
na
na
$ 0.78
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mpox-variant-sparks-global-concern-as-europe-china-ramp-up-screening

Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines ...

 fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

 moderna-stock-moves-after-q1-print-technical-levels-for-the-covid-19-vaccine-play

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground.

 first-vaccine-etf-should-see-halcyon-days-ahead

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX)

 virs-makes-pandemic-vaccine-etf-competition-more-interesting

It was just a week ago that the first exchange-traded fund dedicated to vaccine developers, plenty engaged in the fight against...

 moderna-other-vaccine-developers-lead-the-way-in-new-germ-etf

Vaccines are all the rage these days, both in the medical and investment fields. Now, there's an exchange-traded fund for t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION